Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Frankincense as a Medicine

09.07.2012
Pharmacists of University Jena clarify the anti-inflammatory impact of boswellic acids

It was one of the gifts of the Magi – in addition to myrrh and gold they offered frankincense to the newly born baby Jesus. Since the ancient world the aromatic fragrance of burning Boswellia resin has been part of many religious ceremonies and is still used as a means to indicate special festive atmosphere in the church today.

But frankincense can do much more: “The resin from the trunk of Boswellia trees contains anti-inflammatory substances,“ Professor Dr. Oliver Werz of the Friedrich Schiller University Jena (Germany) says. The chair of Pharmaceutical and Medical Chemistry is convinced that these substances can be very beneficial in therapies against diseases like asthma, rheumatoid arthritis or atopic dermatitis.

However, so far the active substances in frankincense cannot at present be found in drugs in German pharmacies, as the pharmacological impact of frankincense hasn’t been thoroughly investigated. “Although Boswellia resin has been used for thousands of years in the Ayurvedic medicine for instance, the clinical studies we have so far are not suffice for a license in Germany and Europe,“ Professor Werz explains.

But that could change. As part of a mutual project with partners of the University Saarbrücken and a start-up company, Professor Werz and his team examined the curative effect of frankincense. In this project the researchers were able to show where exactly the boswellic acids – which are responsible for the impact of the ingredients of the Boswellia resin – actually interfere in the process of inflammation. “Boswellic acids interact with several different proteins that are part of inflammatory reactions, but most of all with an enzyme which is responsible for the synthesis of prostaglandin E2,” Oliver Werz points out. Prostaglandin E2 is one of the mediators of the immune response and plays a decisive role in the process of inflammation, in the development of fever and of pain. ”Boswellic acids block this enzyme efficiently and thereby reduce the inflammatory reaction,“ the Jena pharmacist explains. With this, not only a targeted use in the therapy of inflammatory diseases is conceivable. It can also be expected that boswellic acids have less side effects than today’s prevalent anti-inflammatory treatments like diclofenac or indometacin. Their impact is less specific, they can increase the risk of stomach ulcers and can negatively affect renal function.

In their latest study the researchers around Professor Werz additionally compared the resin of different kinds of frankincense in its anti-inflammatory impact. There are more than ten Boswellia species in the world. The most well-known and widely-used one is the Boswellia serrata from Northern and central India. “We were able to show that the resin of the Boswellia papyrifera is ten times more potent,” Professor Werz explains a further result of his research. This species mostly occurs in the Northeast of Africa (Ethiopia, Somalia) and on the Arabian Peninsula (Yemen, Oman).

Whether frankincense will become accepted, is indeed not only due to the outcome of the clinical examination which is yet to come. “Boswellic acids exclusively occur in the resin of Boswellia trees and are very difficult to produce synthetically,“ Werz points out. Therefore these trees are the only source of these promising active ingredients. However Boswellia trees are already an endangered tree species. In many places they are just being used as heating fuel. “Thereby without sustained protection not only plant species are endangered but at the same time medicine loses promising active ingredients,” Professor Werz warns.

Contact:
Professor Dr. Oliver Werz
Institute of Pharmacy
Friedrich Schiller University Jena
Philosophenweg 14, D-07743 Jena
Germany
Phone: ++49 3641 949801
Email: oliver.werz[at]uni-jena.de

Dr. Ute Schönfelder | idw
Further information:
http://www.uni-jena.de/

More articles from Life Sciences:

nachricht New way to look at cell membranes could change the way we study disease
19.11.2018 | University of Oxford

nachricht Controlling organ growth with light
19.11.2018 | European Molecular Biology Laboratory

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

New materials: Growing polymer pelts

19.11.2018 | Materials Sciences

Earthquake researchers finalists for supercomputing prize

19.11.2018 | Information Technology

Controlling organ growth with light

19.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>